Clover Health SPAC Presentation Deck

The Path To $25bn In Revenue ~28mm Medicare Advantage Lives expected by 2030(¹) ~40% Of markets in the US(2) 12% Market Share in addressed markets(2) Source: CMS data, census data, and company projections. (1) Individual, non-SNP Market. (2) Company projections.

View entire presentation